...
首页> 外文期刊>Trials >Comparison of effectiveness between warm acupuncture with local-distal points combination and local distribution points combination in breast cancer-related lymphedema patients: a study protocol for a multicenter, randomized, controlled clinical trial
【24h】

Comparison of effectiveness between warm acupuncture with local-distal points combination and local distribution points combination in breast cancer-related lymphedema patients: a study protocol for a multicenter, randomized, controlled clinical trial

机译:乳腺癌相关淋巴米患者局部远端组合与局部分布点组合的疗效比较:多中心,随机,受控临床试验的研究方案

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Lymphedema is the most common complication after breast cancer treatment, but management of lymphedema remains a clinical challenge. Several studies have reported the beneficial effect of acupuncture for treating breast cancer-related lymphedema (BCRL). Our objective is to verify the effectiveness of warm acupuncture on BCRL and compare the effectiveness of a local distribution acupoint combination with a local-distal acupoint combination for BCRL. This is a study protocol for a multicenter, three-arm parallel, assessor blinded, randomized controlled trial. A total of 108 participants diagnosed as BCRL will be randomly allocated in equal proportions to a local distribution acupoint (LA) group, a local-distal acupoint (LDA) group, or a waiting-list (WL) group. The LA and LDA groups will receive 20 acupuncture treatment over 8?weeks with local distribution acupoint combination and local-distal acupoint combination, respectively. The WL group will receive acupuncture treatment after the study is concluded. The primary outcome is the mean change in inter-limb circumference difference from baseline to week 8. The secondary outcomes include volume measurement, skin hardness, common terminology criteria for adverse events 4.03 (edema limbs criteria), stages of lymphedema from the International Society of Lymphology, Disabilities of the Arm, Shoulder and Hand questionnaire, and the Medical Outcome Study 36-item Short-form Health Survey. This study aims to provide data on warm acupuncture as an effective treatment for BCRL and at the same time compare the effectiveness of different acupoint combinations. ClinicalTrials.gov: Identifier NCT03373474 . Registered on 14th December 2017.
机译:淋巴米肿是乳腺癌治疗后最常见的并发症,但淋巴水肿的管理仍然是一个临床挑战。几项研究报告了针灸治疗乳腺癌相关淋巴水肿(BCRL)的有益作用。我们的目标是验证温暖针灸对BCR1的有效性,并比较局部分布穴位组合与BCR1的局部远端穴位组合的有效性。这是一个用于多中心,三臂并联,评估仪的研究方案,随机对照试验。诊断为BCR1的108名参与者将以相等的比例随机分配给本地分发acupoint(la)组,局部远端acupoint(lda)组或等待列表(WL)组。 La和LDA组将分别接受8个以上的针灸治疗,分别具有局部分布穴组合和局部远端穴位组合。研究结束后,WL组将接受针灸治疗。主要结果是从基线到第8周的肢体间圆周差异的平均变化。二次结果包括对不良事件的体积测量,皮肤硬度,常见术语标准4.03(水肿肢标准),来自国际社会的淋巴米阶段的阶段淋巴管,武器,肩部和手持问卷的残疾,以及医疗结果研究36项短型健康调查。本研究旨在为温暖针灸提供对BCRL的有效治疗的数据,同时比较不同穴位组合的有效性。 ClinicalTrials.gov:标识符NCT03373474。 2017年12月14日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号